SCLX
NASDAQScilex Holding Company
News · 26 weeks51-58%
2025-12-142026-06-07
Mix2390d
- SEC Filings12(52%)
- Other5(22%)
- Dividends4(17%)
- Insider2(9%)
Latest news
25 items- PRScilex Holding Company ("Scilex") Announces a Payment Date of June 15, 2026 for the Previously Announced Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity SecuritiesPALO ALTO, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company ("Scilex" or the "Company") (NASDAQ:SCLX), an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that its board of directors (the "Board") has set June 15, 2026 as the payment date (the "Payment Date") for the previously announced dividend of Semnur Pharmaceuticals, Inc. ("Semnur") (OTC:SMNR) common stock held by the Company to its stockholders and certain other eligible holders of Scilex securities (collectively, the "Participati
- SECSEC Form S-3 filed by Scilex Holding CompanyS-3 - Scilex Holding Co (0001820190) (Filer)
- SECSEC Form EFFECT filed by Scilex Holding CompanyEFFECT - Scilex Holding Co (0001820190) (Filer)
- PRScilex Holding Company ("Scilex") Announces Its Board of Directors Approved a Dividend of Semnur Pharmaceuticals, Inc. Common Stock to Holders of Scilex Common Stock and other Eligible Equity Securities with a Record Date of June 1, 2026PALO ALTO, Calif., May 22, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company ("Scilex" or the "Company") (NASDAQ:SCLX), an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that its board of directors (the "Board") approved a dividend of Semnur Pharmaceuticals, Inc. ("Semnur") (OTC:SMNR) common stock held by the Company to its stockholders and certain other eligible equityholders of Scilex (collectively, the "Participating Holders"). The record date for the dividend is June 1, 2026 (the "Record Date"). Th
- SECSEC Form 10-Q filed by Scilex Holding Company10-Q - Scilex Holding Co (0001820190) (Filer)
- SECSEC Form NT 10-Q filed by Scilex Holding CompanyNT 10-Q - Scilex Holding Co (0001820190) (Filer)
- SECScilex Holding Company filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - Scilex Holding Co (0001820190) (Filer)
- SECSEC Form DEFA14A filed by Scilex Holding CompanyDEFA14A - Scilex Holding Co (0001820190) (Filer)
- SECScilex Holding Company filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Scilex Holding Co (0001820190) (Filer)
- PRScilex Holding Company Announces Its Subsidiaries, ACEA Therapeutics, Inc. and ACEA Pharma, Inc., Entered into a Definitive Agreement with Phoenix Asia Holdings LimitedPALO ALTO, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company ("Scilex" or the "Company") (NASDAQ:SCLX), an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that its indirect subsidiary, ACEA Therapeutics, Inc, an exempted company incorporated with limited liability in the Cayman Islands ("ACEA Thera"), ACEA Pharma, Inc., an exempted company incorporated with limited liability in the Cayman Islands and wholly owned subsidiary of ACEA Thera ("ACEA Pharma"), and Phoenix Asia Holdings Limited,
- PRScilex Holding Company Announces Its Board of Directors Approved May 26, 2026 as the Payment Date of the Previously Announced Dividend of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the Record Date of April 30, 2026PALO ALTO, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company ("Scilex" or the "Company") (NASDAQ:SCLX), an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that its board of directors (the "Board") fixed May 26, 2026 (the "Payment Date") as the date on which the previously announced dividend (the "Dividend") of Dream Bowl Meme Coin I tokens held by the Company (the "Dream Bowl Tokens") will be paid to its record stockholders and certain other eligible equityholders of Scilex (collectively,
- SECSEC Form DEF 14A filed by Scilex Holding CompanyDEF 14A - Scilex Holding Co (0001820190) (Filer)
- SECScilex Holding Company filed SEC Form 8-K: Entry into a Material Definitive Agreement8-K - Scilex Holding Co (0001820190) (Filer)
- PRDatavault AI Announces Execution of Binding Term Sheet for $120 Million Cash Contribution From Scilex Holding Company to Fund 100-City GPU Expansion of Quantum-Ready SanQtum PlatformCombined with the anticipated sale of the BTC and Receivable collections, Datavault AI projects $200M+ infusion of cash without equity dilution. Datavault AI has previously secured and in stock of Nvidia GPUs that have a current market value of $1.2 billion that will enable the nationwide roll out. Datavault AI and Scilex have entered into a binding term sheet for a $120 million cash contribution from Scilex, in exchange for the right of Scilex to receive a portion of certain revenues recognized by Datavault AI attributable exclusively to its quantum-ready GPU infrastructure across an estimated 100 cities in the United States (the "Quantum-Ready Edge Network") with the aggregate annu
- PRScilex Holding Company Announces Its Board of Directors Approved a Dividend of Dream Bowl I Meme Coin Tokens to Holders of Common Stock and other Eligible Equity Securities with a Record Date of April 30, 2026PALO ALTO, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company ("Scilex" or the "Company") (NASDAQ:SCLX), an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that its Board of Directors (the "Scilex Board") approved a dividend of Dream Bowl I Meme Coin Tokens held by the Company (the "Dream Bowl Tokens") to its stockholders and certain other eligible equityholders of Scilex (collectively, the "Participating Holders"). The record date for the Dividend is April 30, 2026 (the "Record Date").
- INSIDERSEC Form 4 filed by Ma Stephen Hoi4 - Scilex Holding Co (0001820190) (Issuer)
- INSIDERSEC Form 4 filed by Ji Henry4 - Scilex Holding Co (0001820190) (Issuer)
- SECSEC Form S-3 filed by Scilex Holding CompanyS-3 - Scilex Holding Co (0001820190) (Filer)
- SECSEC Form 10-K filed by Scilex Holding Company10-K - Scilex Holding Co (0001820190) (Filer)
- SECSEC Form NT 10-K filed by Scilex Holding CompanyNT 10-K - Scilex Holding Co (0001820190) (Filer)
- SECScilex Holding Company filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Scilex Holding Co (0001820190) (Filer)
- PRScilex Holding Company Files Federal Securities Fraud Lawsuit Seeking Recovery of Approximately Ninety-Six (96) Million Misappropriated Collateral Shares of Datavault AI, Inc. from Marc Wade, The St. James Bank & Trust Company Ltd., Omega & Corinth Group Ltd., The Bank of New York Mellon Corporation, and Related PartiesPALO ALTO, Calif., March 13, 2026 (GLOBE NEWSWIRE) -- Scilex Holding Company ("Scilex" or the "Company") (NASDAQ:SCLX), an innovative revenue-generating company focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that it has filed a complaint (the "Complaint") in the United States District Court for the Central District of California against Marc Wade, The St. James Bank & Trust Company Ltd. ("St. James Bank"), Omega & Corinth Group Ltd., and related parties (collectively, the "Wade Defendants"), alleging a scheme involving the unauthorized tr
- SECScilex Holding Company filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Scilex Holding Co (0001820190) (Filer)
- SECSEC Form 424B3 filed by Scilex Holding Company424B3 - Scilex Holding Co (0001820190) (Filer)
- SECSEC Form 424B3 filed by Scilex Holding Company424B3 - Scilex Holding Co (0001820190) (Filer)
SCLX FAQ
6 questionsWhere does SCLX stock trade?
Scilex Holding Company (SCLX) is listed on NASDAQ.What sector and industry is SCLX in?
Scilex Holding Company operates in the Health Care sector, Biotechnology: Biological Products (No Diagnostic Substances) industry.When did Scilex Holding Company go public?
Scilex Holding Company (SCLX) completed its IPO in 2021.What are analysts saying about SCLX?
Scilex Holding Company has had 6 recent analyst actions on file. The most recent action was from D. Boral Capital: Buy with a $2200.00 price target on 2025-01-27.What companies are similar to SCLX?
Notable peers in the same industry include AMGN (Amgen Inc.), GILD (Gilead Sciences Inc.), ARGX (argenx SE), RVMD (Revolution Medicines Inc.), BIIB (Biogen Inc.). Compare SCLX side-by-side with any of them on Quantisnow.How can I track SCLX on Quantisnow?
Quantisnow aggregates Scilex Holding Company's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SCLX to receive live email and push alerts on every new disclosure.